TY - JOUR
T1 - Racial Disparities in Clinical Outcomes and Resource Utilization of Type 2 Myocardial Infarction in the United States
T2 - Insights From the National Inpatient Sample Database
AU - Mhanna, Mohammed
AU - Minhas, Abdul Mannan Khan
AU - Ariss, Robert W.
AU - Nazir, Salik
AU - Khan, Safi U.
AU - Vaduganathan, Muthiah
AU - Blankstein, Ron
AU - Alam, Mahboob
AU - Nasir, Khurram
AU - Virani, Salim S.
N1 - Funding Information:
Disclosures : Dr. Vaduganathan has received research grant support or served on advisory boards for American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, Boehringer Ingelheim, Cytokinetics, Lexicon Pharmaceuticals, Relypsa, and Roche Diagnostics, speaker engagements with Novartis and Roche Diagnostics, and participates on clinical endpoint committees for studies sponsored by Galmed and Novartis. Salim S. Virani, MD, PhD: Research grant funding: Department of Veterans Affairs, World Heart Federation, Tahir and Jooma Family. Honorarium: American College of Cardiology (Associate Editor for Innovations. Acc.org All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2023/8
Y1 - 2023/8
N2 - Race-based differences in clinical outcomes have been well described in type 1 myocardial infarction. However, type 2 myocardial infarction (T2MI) is more common in contemporary practice, with scarce data regarding racial differences in outcomes. The National Inpatient Sample Database October 2017-December 2018 was queried for hospitalizations with T2MI. Complex samples multivariable logistic and linear regression models were used to determine the association between T2MI and outcomes (in-hospital mortality, length of stay [LOS], hospital costs, and discharge to facility among different racial groups (White, Black, Hispanic, and Other-races/ethnicities [Native American, Asian or Pacific Islander and others]). A total of 294,540 hospitalizations [209,565 (71.2%) White patients, 47,105 (16%) Black patients, 22,115 (7.5%) Hispanic patients, and 15,755 (5.3%) Other-races/ethnicities patients] carrying a primary or secondary diagnosis of T2MI were included in this analysis. Compared to White patients with T2MI; Other-races/ethnicities patients were associated with higher in-hospital mortality (adjusted odds ratio [aOR] 1.17; 95% confidence interval [CI]1.03-1.33; P = 0.016), and longer LOS. Hospital costs were higher for Hispanic and Other-races/ethnicities patients compared to White patients with T2MI. Further, all the racial/ethnicity groups were less likely to be discharged to facility compared to White patients. Although Black and Hispanic patients with T2MI have similar in-hospital mortality compared with White patients, other racial minorities have higher in-hospital mortality among patients with T2MI compared to White patients. Furthermore, White patients were more likely to be discharged to a facility. Further prospective investigations of the impact of racial differences on T2MI-related in-hospital mortality and disposition are warranted.
AB - Race-based differences in clinical outcomes have been well described in type 1 myocardial infarction. However, type 2 myocardial infarction (T2MI) is more common in contemporary practice, with scarce data regarding racial differences in outcomes. The National Inpatient Sample Database October 2017-December 2018 was queried for hospitalizations with T2MI. Complex samples multivariable logistic and linear regression models were used to determine the association between T2MI and outcomes (in-hospital mortality, length of stay [LOS], hospital costs, and discharge to facility among different racial groups (White, Black, Hispanic, and Other-races/ethnicities [Native American, Asian or Pacific Islander and others]). A total of 294,540 hospitalizations [209,565 (71.2%) White patients, 47,105 (16%) Black patients, 22,115 (7.5%) Hispanic patients, and 15,755 (5.3%) Other-races/ethnicities patients] carrying a primary or secondary diagnosis of T2MI were included in this analysis. Compared to White patients with T2MI; Other-races/ethnicities patients were associated with higher in-hospital mortality (adjusted odds ratio [aOR] 1.17; 95% confidence interval [CI]1.03-1.33; P = 0.016), and longer LOS. Hospital costs were higher for Hispanic and Other-races/ethnicities patients compared to White patients with T2MI. Further, all the racial/ethnicity groups were less likely to be discharged to facility compared to White patients. Although Black and Hispanic patients with T2MI have similar in-hospital mortality compared with White patients, other racial minorities have higher in-hospital mortality among patients with T2MI compared to White patients. Furthermore, White patients were more likely to be discharged to a facility. Further prospective investigations of the impact of racial differences on T2MI-related in-hospital mortality and disposition are warranted.
UR - http://www.scopus.com/inward/record.url?scp=85129970587&partnerID=8YFLogxK
U2 - 10.1016/j.cpcardiol.2022.101202
DO - 10.1016/j.cpcardiol.2022.101202
M3 - Review article
C2 - 35398361
AN - SCOPUS:85129970587
SN - 0146-2806
VL - 48
JO - Current Problems in Cardiology
JF - Current Problems in Cardiology
IS - 8
M1 - 101202
ER -